Table 2 Uni- and multivariate analyses for prognosis

CR/PR vs SD/PD

<0.001

0.23 (0.12–0.45)

−1.30

0.37

<0.001

0.27 (0.13–0.56)

Second-line chemotherapy none vs done

<0.001

3.60 (2.03–6.37)

0.98

0.40

0.013

2.67 (1.23–5.78)

GS none vs done

0.009

2.05 (1.19–3.52)

0.21

0.34

0.53

1.24 (0.64–2.39)

Radiation none vs done

0.009

2.21 (1.22–4.01)

0.13

0.39

0.73

1.14 (0.53–2.45)

No ascites vs development of ascites at 1 year

<0.001

0.39 (0.23–0.65)

−0.12

0.31

0.70

0.89 (0.48–1.63)

LA/CY vs P/L

0.015

0.51 (0.30–0.88)

−0.11

0.32

0.72

0.89 (0.48–1.68)